Atıf İçin Kopyala
ARTAÇ M., COŞKUN H. Ş. , Korkmaz L., Kocer M. , Turhal N. S. , ENGİN H., ...Daha Fazla
CLINICAL GENITOURINARY CANCER, cilt.14, 2016 (SCI İndekslerine Giren Dergi)
Survival outcomes of interferon-alfa and tyrosine kinase inhibitors for 104 cases of metastatic renal cell carcinoma were included in this study. First-line interferon-alfa treatment before tyrosine kinase inhibitors had an additive survival affect.